Dr. Richard Yu, PhD

CEO and Co-founder at Abalone Bio

Speaker

Richard Yu, co-founder, CEO, and board director Ph.D., Mol. Biochemistry & Biophysics, 2000 Yale University. Richard’s path to co-founding Abalone Bio started at UC Berkeley in Physics, Biophysics, and Computer Science, and wound its way through early efforts at protein secondary structure prediction with Teresa Head-Gordon at UC Berkeley/LBNL, then to protein engineering and structural biology with Axel Brunger at Yale. After receiving his PhD, he worked in one of the first systems biology and synthetic biology interdisciplinary efforts with Roger Brent and Sydney Brenner at the Molecular Sciences Institute, where he met co-founder Gustavo Pesce. Abalone Bio grew out of an "a-ha!" moment that produced an antibody discovery and design technology that uniquely combines their genetics, synthetic biology, quantitative biology, and computational skillsets to meet a long-standing therapeutic need for safe and effective drugs for challenging drug targets like GPCRs.